Werke:
- Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness
- Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer
- Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
- A transcriptional response to replication stress selectively expands a subset of Brca2-mutant mammary epithelial cells